Regulation of μ and δ opioid receptor functions: involvement of cyclin‐dependent kinase 5

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|172|10|2573-2587

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.10, 2015-05, pp. : 2573-2587

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase 2 trial of the cyclin‐dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein‐expressing germ cell tumors

By  

CANCER, Vol. 121, Iss. 9, 2015-05 ,pp. : 1463-1468

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epigenetic Silencing of MicroRNA miR-107 Regulates Cyclin-Dependent Kinase 6 Expression in Pancreatic Cancer

By  

Pancreatology, Vol. 9, Iss. 3, 2009-04 ,pp. : 293-301

Karger

Access to resources Recommend Favorite

Expression and Prognostic Role of Cyclin-Dependent Kinase 1 (cdc2) in Hepatocellular Carcinoma

By  

Oncology, Vol. 59, Iss. 1, 2000-06 ,pp. : 68-74

Karger

Access to resources Recommend Favorite

Assignment1 of CDK5R2 coding for the cyclin-dependent kinase 5, regulatory subunit 2 (NCK5AI protein) to human chromosome band 2q35 by fluorescent in situ hybridization

By  

Cytogenetic and Genome Research, Vol. 89, Iss. 3-4, 2000-08 ,pp. : 160-161

Karger

Access to resources Recommend Favorite

Assignment1 of the cyclin-dependent kinase inhibitor genes Cdkn2a and Cdkn2b to rat chromosome bands 5q32→q34 and 5q31→q33, respectively by fluorescence in situ hybridization, using small PCR-generated probes

By  

Cytogenetic and Genome Research, Vol. 81, Iss. 3-4, 1998-09 ,pp. : 290-291

Karger

Access to resources Recommend Favorite